2m 2m 2m 2m 2m 2m 2m
KYMERA THERAP (KYMR)
NASDAQ
$110.98-$1.65 (-1.46%)
Price as of Oct 22, 2026 7:30 PM EDT- $9.4BMarket Cap
- 101.85%1-Year Change
- BiotechnologyIndustry
KYMERA THERAP (KYMR)
$110.98-$1.65 (-1.46%)
KYMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $112.63 | ||
Change | -$0.83 (-0.73%) | ||
Open | $113.38 | ||
High | $115.75 | ||
Low | $112.52 | ||
Previous Close | $113.46 | ||
Volume | 1,056,209 | ||
30-Day Average Volume | 841,776 | ||
1-Week Change | 5.43% | ||
1-Month Change | -4.28% | ||
1-Year Change | 101.85% | ||
3-Year Change | 827.00% | ||
5-Year Change | 105.64% | ||
Fundamentals | |||
Shares Outstanding | 83.2M | ||
Total Assets | $1.6B | ||
Market Cap | $9.4B | ||
Enterprise Value | $9.2B | ||
Period: QTR TTM FY | |||
Revenue | $65.0M | ||
Net Income | -$61.2M | ||
Free Cash Flow | -$54.5M | ||
EBIT | -$61.1M | ||
EBITDA | -$59.1M | ||
Net Working Capital | $665.9M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -156 | ||
Enterprise Value/Revenue | 142 | ||
P/B | 6 | ||
P/E | -182 | ||
PEG | -14 | ||
Price/Free Cash Flow | -172 | ||
Price/Operating Cash Flow | -173 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue